The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
Journal of Global Health · 15.09.2023 · 13
DOI: 10.7189/jogh.13.04109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health, online erschienen am 15.09.2023. Verfasst von Yanting Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms. Die Arbeit wurde bisher 209-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China.
- Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
- Department of Cancer Prevention, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Förderung
- World Health Organization
Zitieren
APA
Zhang, Y., Rumgay, H., Li, M., Yu, H., Pan, H., & Ni, J. (2023). The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. Journal of Global Health, 13. https://doi.org/10.7189/jogh.13.04109
Vancouver
Zhang Y, Rumgay H, Li M, Yu H, Pan H, Ni J. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. Journal of Global Health. 2023;13. doi:10.7189/jogh.13.04109
BibTeX
@article{Zhang2023,
author = {Zhang, Yanting and Rumgay, Harriet and Li, Mengmeng and Yu, Haibing and Pan, Haiyan and Ni, Jindong},
title = {The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040},
journal = {Journal of Global Health},
year = {2023},
volume = {13},
doi = {10.7189/jogh.13.04109}
}
EUVIMED